American Telemedicine Association Welcomes John Glaser, PhD to its Board of Directors

 

Washington, DC, January 14, 2015 -- John Glaser, PhD, has recently joined the Board of Directors of the American Telemedicine Association (ATA). Glaser joins an esteemed group of directors that provides guidance for the association, which has a mission to promote professional, ethical and equitable improvement in healthcare delivery through telecommunications and information technology.

Glaser has had a long and distinguished career as a world-wide leader in health technology on both the clinical and industry sides. He currently serves as CEO of the Health Services Business Unit of Siemens Healthcare but, upon the completion of the unit’s acquisition by Cerner, will join Cerner as Senior Vice President. At Siemens Glaser is responsible for heading the company’s global healthcare IT business. In this capacity, he leads over 4,500 employees, multiple health information system brands, a robust Global Services arm, and Siemens’ renowned Information Systems Center.

“John comes to ATA with an extensive background as a leader in health information technology,” said Jonathan Linkous, CEO of ATA. “His experience as CIO of a major provider institution, and as a leader in both the federal government and private sector, lends a valuable perspective to the Board. The association will benefit immensely from his vision and leadership.”

Prior to joining Siemens, Glaser was Vice-President and Chief Information Officer at Partners HealthCare, Inc. Previously, he was Vice-President, Information Systems at Brigham and Women's Hospital. Glaser was the founding chairman of the College of Healthcare Information Management Executives (CHIME), and is the former chairman of the eHealth Initiative Board and the Board of the National Alliance for Health Information Technology. He is a former Senior Advisor to the Office of the National Coordinator for Health Information Technology (ONC). He is also past president of the Healthcare Information & Management Systems Society (HIMSS), and is a fellow of HIMSS, CHIME, and the American College of Medical Informatics, where he previously served on the board. He is a frequent speaker on health information technology and delivered a keynote address at the 2003 ATA Annual Meeting.

Glaser joins an influential group of leading clinicians, technology and business leaders on the ATA Board of Directors. A full list of the ATA Board is available at http://www.americantelemed.org/board.

About the American Telemedicine Association

The American Telemedicine Association is the leading international resource and advocate promoting the use of advanced remote medical technologies. ATA and its diverse membership work to fully integrate telemedicine into healthcare systems to improve quality, equity and affordability of healthcare throughout the world. Established in 1993, ATA is headquartered in Washington, DC. For more information, visit http://www.americantelemed.org.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.